These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 19672860
21. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Barbolina MV, Adley BP, Shea LD, Stack MS. Cancer; 2008 Apr 01; 112(7):1632-41. PubMed ID: 18260155 [Abstract] [Full Text] [Related]
27. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM. Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421 [Abstract] [Full Text] [Related]
28. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma. Aguirre D, Boya P, Bellet D, Faivre S, Troalen F, Benard J, Saulnier P, Hopkins-Donaldson S, Zangemeister-Wittke U, Kroemer G, Raymond E. Apoptosis; 2004 Nov 01; 9(6):797-805. PubMed ID: 15505422 [Abstract] [Full Text] [Related]
31. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo. Li R, Liu T, Shi J, Luan W, Wei X, Yu J, Mao H, Liu P. J Transl Med; 2019 Dec 26; 17(1):428. PubMed ID: 31878941 [Abstract] [Full Text] [Related]
34. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R. Int J Cancer; 2005 Jan 20; 113(3):372-8. PubMed ID: 15455382 [Abstract] [Full Text] [Related]
35. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B. Cancer; 2005 Apr 15; 103(8):1631-43. PubMed ID: 15742334 [Abstract] [Full Text] [Related]
36. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients. Feng H, Yu Z, Tian Y, Lee YY, Li MS, Go MY, Cheung YS, Lai PB, Chan AM, To KF, Chan HL, Sung JJ, Cheng AS. J Hepatol; 2015 May 15; 62(5):1100-11. PubMed ID: 25500144 [Abstract] [Full Text] [Related]
37. CCRK depletion inhibits glioblastoma cell proliferation in a cilium-dependent manner. Yang Y, Roine N, Mäkelä TP. EMBO Rep; 2013 Aug 15; 14(8):741-7. PubMed ID: 23743448 [Abstract] [Full Text] [Related]
39. SOX2 expression associates with stem cell state in human ovarian carcinoma. Bareiss PM, Paczulla A, Wang H, Schairer R, Wiehr S, Kohlhofer U, Rothfuss OC, Fischer A, Perner S, Staebler A, Wallwiener D, Fend F, Fehm T, Pichler B, Kanz L, Quintanilla-Martinez L, Schulze-Osthoff K, Essmann F, Lengerke C. Cancer Res; 2013 Sep 01; 73(17):5544-55. PubMed ID: 23867475 [Abstract] [Full Text] [Related]
40. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. Güller M, Toualbi-Abed K, Legrand A, Michel L, Mauviel A, Bernuau D, Daniel F. World J Gastroenterol; 2008 Nov 07; 14(41):6339-46. PubMed ID: 19009649 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]